Literature DB >> 35450180

Phenotypic appearance of central retinal vein occlusion post AstraZeneca vaccine.

Peter Cackett1,2, Rinoza Bafiq1, Ahmed Ali1, Su Ling Young1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35450180      PMCID： PMC8995738          DOI： 10.18240/ijo.2022.04.24

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN： 2222-3959            Impact factor:   1.779


× No keyword cloud information.
  4 in total

1.  Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.

Authors:  Nina H Schultz; Ingvild H Sørvoll; Annika E Michelsen; Ludvig A Munthe; Fridtjof Lund-Johansen; Maria T Ahlen; Markus Wiedmann; Anne-Hege Aamodt; Thor H Skattør; Geir E Tjønnfjord; Pål A Holme
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245

2.  Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.

Authors:  Andreas Greinacher; Thomas Thiele; Theodore E Warkentin; Karin Weisser; Paul A Kyrle; Sabine Eichinger
Journal:  N Engl J Med       Date:  2021-04-09       Impact factor: 91.245

3.  Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.

Authors:  Anton Pottegård; Lars Christian Lund; Øystein Karlstad; Jesper Dahl; Morten Andersen; Jesper Hallas; Øjvind Lidegaard; German Tapia; Hanne Løvdal Gulseth; Paz Lopez-Doriga Ruiz; Sara Viksmoen Watle; Anders Pretzmann Mikkelsen; Lars Pedersen; Henrik Toft Sørensen; Reimar Wernich Thomsen; Anders Hviid
Journal:  BMJ       Date:  2021-05-05

4.  Central retinal vein occlusion occurring immediately after 2nd dose of mRNA SARS-CoV-2 vaccine.

Authors:  A A Bialasiewicz; M S Farah-Diab; H T Mebarki
Journal:  Int Ophthalmol       Date:  2021-08-23       Impact factor: 2.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.